Dosage Form Proportionality of Opicapone To-Be-Marketed Formulation
Clinical trial NCT02305329 · COMPLETED
Trial details
- NCT number
- NCT02305329
- Sponsor
- Bial - Portela C S.A.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-02-01
- Primary completion
- 2014-04-01
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.